
Continuous Glucose Monitoring - Congenital hyperinsulinism
You are here : Home > Formulary Search > Continuous Glucose Monitoring - Congenital hyperinsulinism
Status 1
- Device
Patients must be under the care of a national CHI centre (see narrative for details).
Documentation
- No records returned.
PAD Profile
Other Indications
Below are listed other indications that Continuous Glucose Monitoring is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Congenital hyperinsulinism.
- No records returned.
Committee Recommendations (1)
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approves real time continuous glucose monitoring (RTCGM) devices for patients with congenital hyperinsulinism (CHI) who are under the care of one of the 3 nationally commissioned centres:
· Great Ormond Street Hospital for Children NHS Foundation Trust
· Manchester University NHS Foundation Trust
· Alder Hey Children’s NHS Foundation Trust
AND who require overnight continuous enteral glucose delivery via a gastrostomy feed pump. rtCGM acts as an additional alert in case of gastrostomy feed pump failure.
RTCGM will be given a RED traffic light status for this indication.